Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
AB Sciex

Solid Media Used to Isolate Leptospira

By Labmedica International staff writers
Posted on 25 Feb 2013
Image: Leptospira interrogans (Photo courtesy of Science Photo Library).
Image: Leptospira interrogans (Photo courtesy of Science Photo Library).
Isolation of Leptospira, from clinical samples and testing of antimicrobial susceptibility are difficult and time-consuming.

Pathogenic Leptospira are slow-growing Gram-negative spirochetes and a new solid medium that facilitates more-rapid growth of these organisms has been developed

Microbiologists at the Mahidol University (Bangkok, Thailand) developed the new solid medium, called LVW agar, by testing the effects of combinations of ingredients and incubation conditions. All recipes contained three core ingredients and a variable concentration of two additional ingredients. A total of 109 pathogenic Leptospira isolates were used during the development and evaluation of the new solid medium and Etest, which is well-established method for antimicrobial resistance testing, antibiotic susceptibility testing in microbiology laboratories around the world.

The medium was developed by evaluating the effects of numerous factors on the growth rate of a strain of Leptospira interrogans. These included the type of base agar, the concentration of rabbit serum (RS), and the concentration and duration of carbon dioxide (CO2) incubation during the initial period of culture. The highest growth rate of this strain was achieved using a Noble agar base supplemented with 10% RS and named LVW agar, with an initial incubation at 30 °C in 5% CO2 for two days prior to continuous culture in air at 30 °C.

These conditions were used to develop the Etest for three species, L. interrogans, L. kirschnerii, and L. borgpetersenii. The minimum inhibitory concentrations (MICs) were read on day seven for all samples. The validated Etest methodology was performed for 109 Leptospira isolates with five antimicrobial drugs, penicillin G, doxycycline, ceftriaxone, cefotaxime, and chloramphenicol. The MIC90 values were as follows: penicillin G, 0.064 units/mL; doxycycline, 0.19 µg/mL; cefotaxime, 0.047 µg/mL; ceftriaxone, 0.5 µg/mL; and chloramphenicol, 2 µg/mL.

Leptospirosis is a zoonotic disease that has a worldwide distribution but has the greatest impact on health in developing countries, where it is often grossly under recognized. The authors concluded that LVW agar that enables rapid growth, isolation of single colonies, and simple antimicrobial susceptibility testing for Leptospira species will become widely used in diagnostic microbiology laboratories, but especially in resource-limited settings. The study was published in the January 2013 issue of the journal Antimicrobial Agents and Chemotherapy.

Related Links:

Mahidol University




GREINER-BIO-ONE
ADVANCED INSTRUMENTS
PURITAN MEDICAL
BioConferenceLive

Channels

Genetic Tests

view channel
Image: The QuantiTect Reverse Transcription Kit (Photo courtesy of Qiagen)

Blood Tests Predict Risk of Sudden Cardiac Death

A simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).... Read more

Hematology

view channel

Blood Donations Screened for Viruses Using Multiplex Assay

A global healthcare company was chosen to partner the Japanese Red Cross (JRC; Tokyo, Japan) for nucleic acid screening of the nation's blood supply. Under the terms of the 7-year agreement, the healthcare company, Grifols (Barcelona, Spain) will provide the JRC with its newest automation platform, the Procleix Panther... Read more

Pathology

view channel

Gene Profile Predicts Risk of Bladder Cancer Recurrence

A genomic study has pinpointed several markers that identify bladder cancer patients at risk of recurrence and that may be indicators of overall survival status. Nearly half of patients with bladder cancer experience recurrences, so reliable predictors of this recurrent phenotype are needed to guide surveillance and treatment.... Read more

Industry News

view channel

Beckman Coulter and hc1.com Enter Strategic Partnership for Innovative Healthcare Cloud System

The diagnostics division of Beckman Coulter (Brea, CA, USA) and hc1.com (Indianapolis, IN, USA) have announced a partnership to bring an innovative healthcare cloud-technology system to clinical laboratories. The system, hc1.com's "Healthcare Relationship Cloud," helps turn large amounts of clinical data into actionable... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.